This website uses cookies to improve your experience.

Cookie policy

Emergency department resuscitative endovascular balloon occlusion of the aorta in trauma patients with exsanguinating hemorrhage. The UK-REBOA randomized clinical trial

Jansen O, Hudson J, Cochran C, MacLennan G, Lendrum R, Sadek S et al, and the UK-REBOA Study Group

JAMA 2023; 330: 1862-1871.

A total of 90 patients were included. After 90 days, the overall mortality rate was higher after use of the REBOA than standard care: 54 versus 42 per cent (odds ratio 1.58, 95 per cent confidence interval 0.72 to 3.52).

Comment: Disappointing, and deserves more explanation and discussion.

Read paper


Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.

The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.

Discover the Academy
Surgeon Training & Surgeons in Surgery